Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Syneron Candela dumps Olympic swimmer Ryan Lochte
Syneron Candela this week severed its ties with Olympic swimmer Ryan Lochte, who was a spokesman for the aesthetic device company’s Gentle Hair Removal brand.
“We hold our employees to high standards, and we expect the same of our business partners,” Yokneam, Israel-based Syneron Candela said. “We wish Ryan well on his future endeavors and thank him for the time he spent supporting our brand.” Read more
4. SRS Medical launches Spanner prostate device study
SRS Medical Systems said today it enrolled the 1st patients in an FDA investigational device exemption study as it seeks to expand the indications for its Spanner temporary prostatic stent.
The Spanner device consists of a pair of anchors and a silicone tube and is designed to reduce resistance in the bladder neck and prostatic urethra without stenting the external sphincter, SRS said. It’s blind, anesthesia-free implantation procedure is similar to that for a Foley catheter, according to the company. Read more
3. Senators press Mylan on EpiPen price hike
Sens. Amy Klobuchar (D-Minn.) and Charles Grassley (R-Iowa) are pressing Mylan for information on its 400% price increase for the EpiPen epinephrine auto-injector, which went from $100 in 2008 to more than $500 despite stable manufacturing costs.
The pressure comes amid a nationwide discussion about price-gouging, after Turing Pharmaceuticals came under fire for raising the price of Daraprim from $13.50 to $750 a pill. Read more
2. Fitbit escapes Jawbone’s trade secret theft claims
Fitbit yesterday beat rival Jawbone‘s accusations that it stole trade secrets for its wearable fitness tracking device when a judge for the U.S. International Trade Commission ruled that there were no violations of the Tariff Act because “no party has been shown to have misappropriated any trade secret.”
The decision by Judge Dee Lord spikes Jawbone’s attempt to block imports of the Fitbit devices, part of its ITC complaint alleging that Fitbit infringes 6 of its patents and poached workers who brought confidential data with them when they jumped ship – including plans, supply chains and technical details. Read more
1. Sirtex Medical jumps on surging sales, profits for fiscal 2016
Shares in Sirtex Medical closed up nearly 12% today after the Australian medical device company posted huge boosts to both the bottom and top lines.
Sydney-based Sirtex Medical makes targeted liver cancer therapies using resin microspheres called SIR-sphere Y-90. Read more
The post MassDevice.com +5 | The top 5 medtech stories for August 24, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/2biHbH1
Cap comentari:
Publica un comentari a l'entrada